Clinical Study | Office of Clinical Research

Roxadustat For Anemia In Esrd On Dialysis At Dci Clinics

Posted Date: May 15, 2019

Investigator: Suresh Kamath
Type of Study: Drug

This study is being carried out to see if a new investigational drug called roxadustat is safe and effective in treating anemia in patients with chronic kidney disease who are on dialysis and if so, how it compares with epoetin alfa (EPO) treatment. EPO is approved for treatment of anemia.

Criteria:

On Dialysis At Dci Mcmillan Or Dci Western Hills. Hgb <12, Adequate Tsat And Ferritin. No Prior Tr

Keywords:

Erythropoeisis Stimu, Anemia, Hif-Phi, Dialysis

For More Information:

Heather J Duncan, Phd
513-559-3362
heather.duncan@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List